These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32619646)

  • 41. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.
    Boyano MD; García-Vázquez MD; Gardeazabal J; García de Galdeano A; Smith-Zubiaga I; Cañavate ML; Raton JA; Bilbao I; Díaz-Pérez JL
    Oncology; 1997; 54(5):400-6. PubMed ID: 9260602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
    Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma.
    Tisi E; Lissoni P; Angeli M; Arrigoni C; Corno E; Cassina E; Ballabio D; Benenti C; Barni S; Tancini G
    Cancer; 1992 May; 69(10):2458-62. PubMed ID: 1314691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
    Peter JB; Boctor FN; Tourtellotte WW
    Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.
    Gooding R; Riches P; Dadian G; Moore J; Gore M
    Br J Cancer; 1995 Aug; 72(2):452-5. PubMed ID: 7640231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
    Siemińska A
    Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
    Bien E; Balcerska A
    Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
    Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
    Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
    Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the soluble murine IL-2R and estimation of its affinity for IL-2.
    Baran D; Korner M; Theze J
    J Immunol; 1988 Jul; 141(2):539-46. PubMed ID: 3133411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-2 receptor signaling: at the interface between tolerance and immunity.
    Malek TR; Castro I
    Immunity; 2010 Aug; 33(2):153-65. PubMed ID: 20732639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study on cellular immunity in children with respiratory syncytial virus associated acute lower respiratory infection].
    Chen Z; Dong Y; Zhang M; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):263-6. PubMed ID: 15617344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Clin Exp Rheumatol; 1996; 14(4):413-6. PubMed ID: 8871841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting human IL-2 receptors for diagnosis and therapy.
    Nelson DL; Kurman CC
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):309-11. PubMed ID: 8016170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The significance of soluble IL-2 receptors in rheumatoid arthritis with interstitial pneumonia].
    Tada S; Namba J; Yokota S; Sugimoto K; Imajo K; Kawabata H; Irie S; Kimura I; Kitani H; Tanizaki K
    Arerugi; 1992 Mar; 41(3):428-33. PubMed ID: 1575640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.